Tao Synergies Inc. (TAOX) — 10-Q Filings

10-Q Filings (6)

• TAOX Plunges into Crypto, Reports $21M Loss Amid Digital Asset Volatility — Nov 14, 2025 Risk: high
  TAO Synergies Inc. (TAOX) reported a significant net loss of $21,054,156 for the nine months ended September 30, 2025, a substantial increase from the $7,222,02
• TAOX Pivots to Crypto, Reports $17.1M Loss Amidst Strategic Shift — Aug 14, 2025 Risk: high
  TAO Synergies Inc. (TAOX) reported a significant net loss of $17.13 million for the six months ended June 30, 2025, a substantial increase from the $1.48 millio
• Synaptogenix Q1 2025 10-Q Filed — May 15, 2025 Risk: low
  Synaptogenix, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Neurotrope Bioscience, Inc., reported total assets of $3,
• Synaptogenix Reports Q3 Loss, Revenue Growth — Nov 12, 2024 Risk: medium
  Synaptogenix, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported a net loss of $1.32 million for the three months ended Septembe
• Synaptogenix, Inc. Files 10-Q, Discloses Financial Inputs — Aug 14, 2024 Risk: medium
  Synaptogenix, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Neurotrope Bioscience, Inc., is in the pharmaceutical prep
• Synaptogenix, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  Synaptogenix, Inc. (TAOX) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Synaptogenix, Inc. reported total assets of $1,085,237 and total debt of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX